Brain scans reveal clues about rare neurological disease
NCT ID NCT01136213
First seen May 30, 2026 · Last updated Jun 15, 2026 · Updated 2 times
Summary
This study looked at how the brain chemical serotonin works in people with multiple system atrophy (MSA), a rare and serious brain disease. Researchers used special PET scans to measure serotonin receptors in 53 participants, including those with MSA and Parkinson's disease. The goal was to learn more about the disease, not to test a treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SYSTEM ATROPHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Limoges
Limoges, France
-
CHU de Bordeaux
Bordeaux, 33076, France
-
CHU de Toulouse
Toulouse, 31059, France
Conditions
Explore the condition pages connected to this study.